# OnCo record idea-acc-biosimilar-prequalification-pool (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-acc-biosimilar-prequalification-pool/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-acc-biosimilar-prequalification-pool" ;
  schema:name "WHO prequalification plus pooled demand to push biosimilar prices below 10% of the originator"@en ;
  schema:description "Biosimilars of trastuzumab, rituximab and bevacizumab have existed for years, but poorer countries cannot assess biologics themselves and place small fragmented orders. Extending WHO prequalification, begun with trastuzumab in 2019, to every oncology biosimilar and pooling procurement would give buyers assurance and makers volume, aiming below a tenth of originator prices."@en ;
  schema:url <https://onco.cc/ideas/idea-acc-biosimilar-prequalification-pool/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://www.who.int/news-room/fact-sheets/detail/cancer> ;
  onco:cancers <https://onco.cc/cancers/breast-her2-positive/>, <https://onco.cc/cancers/dlbcl/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:drugs <https://onco.cc/drugs/trastuzumab/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-global-access/>, <https://onco.cc/bottlenecks/b-drug-pricing/>, <https://onco.cc/bottlenecks/b-regulatory-fragmentation/> .